153 related articles for article (PubMed ID: 22301880)
21. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
Bögi K; Lorenzo PS; Szállási Z; Acs P; Wagner GS; Blumberg PM
Cancer Res; 1998 Apr; 58(7):1423-8. PubMed ID: 9537243
[TBL] [Abstract][Full Text] [Related]
22. C1 domains exposed: from diacylglycerol binding to protein-protein interactions.
Colón-González F; Kazanietz MG
Biochim Biophys Acta; 2006 Aug; 1761(8):827-37. PubMed ID: 16861033
[TBL] [Abstract][Full Text] [Related]
23. Conformation of the C1 phorbol-ester-binding domain participates in the activating conformational change of protein kinase C.
Ho C; Slater SJ; Stagliano BA; Stubbs CD
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):451-60. PubMed ID: 10567228
[TBL] [Abstract][Full Text] [Related]
24. Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions.
Kang JH; Benzaria S; Sigano DM; Lewin NE; Pu Y; Peach ML; Blumberg PM; Marquez VE
J Med Chem; 2006 Jun; 49(11):3185-203. PubMed ID: 16722637
[TBL] [Abstract][Full Text] [Related]
25. Macrocyclic diacylglycerol-bis-lactones as conformationally constrained analogues of diacylglycerol-lactones. Interactions with protein kinase C.
Kang JH; Kim SY; Lee J; Marquez VE; Lewin NE; Pearce LV; Blumberg PM
J Med Chem; 2004 Jul; 47(16):4000-7. PubMed ID: 15267238
[TBL] [Abstract][Full Text] [Related]
26. Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C.
Majhi A; Rahman GM; Panchal S; Das J
Bioorg Med Chem; 2010 Feb; 18(4):1591-8. PubMed ID: 20100661
[TBL] [Abstract][Full Text] [Related]
27. The C4 hydroxyl group of phorbol esters is not necessary for protein kinase C binding.
Tanaka M; Irie K; Nakagawa Y; Nakamura Y; Ohigashi H; Wender PA
Bioorg Med Chem Lett; 2001 Mar; 11(5):719-22. PubMed ID: 11266177
[TBL] [Abstract][Full Text] [Related]
28. Identification of a general anesthetic binding site in the diacylglycerol-binding domain of protein kinase Cdelta.
Das J; Addona GH; Sandberg WS; Husain SS; Stehle T; Miller KW
J Biol Chem; 2004 Sep; 279(36):37964-72. PubMed ID: 15234976
[TBL] [Abstract][Full Text] [Related]
29. Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.
Pak Y; Enyedy IJ; Varady J; Kung JW; Lorenzo PS; Blumberg PM; Wang S
J Med Chem; 2001 May; 44(11):1690-701. PubMed ID: 11356104
[TBL] [Abstract][Full Text] [Related]
30. Diacylglycerol kinase gamma is one of the specific receptors of tumor-promoting phorbol esters.
Shindo M; Irie K; Ohigashi H; Kuriyama M; Saito N
Biochem Biophys Res Commun; 2001 Nov; 289(2):451-6. PubMed ID: 11716494
[TBL] [Abstract][Full Text] [Related]
31. Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
Nacro K; Bienfait B; Lee J; Han KC; Kang JH; Benzaria S; Lewin NE; Bhattacharyya DK; Blumberg PM; Marquez VE
J Med Chem; 2000 Mar; 43(5):921-44. PubMed ID: 10715158
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.
Choi SH; Czifra G; Kedei N; Lewin NE; Lazar J; Pu Y; Marquez VE; Blumberg PM
J Biol Chem; 2008 Apr; 283(16):10543-9. PubMed ID: 18263588
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and structure-activity relationship of new isobenzofuranone ligands of protein kinase C.
Baba Y; Ogoshi Y; Hirai G; Yanagisawa T; Nagamatsu K; Mayumi S; Hashimoto Y; Sodeoka M
Bioorg Med Chem Lett; 2004 Jun; 14(11):2963-7. PubMed ID: 15125969
[TBL] [Abstract][Full Text] [Related]
34. Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs.
Johnson JE; Goulding RE; Ding Z; Partovi A; Anthony KV; Beaulieu N; Tazmini G; Cornell RB; Kay RJ
Biochem J; 2007 Sep; 406(2):223-36. PubMed ID: 17523924
[TBL] [Abstract][Full Text] [Related]
35. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
Irie K; Nakagawa Y; Ohigashi H
Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
[TBL] [Abstract][Full Text] [Related]
36. New insights into the regulation of protein kinase C and novel phorbol ester receptors.
Ron D; Kazanietz MG
FASEB J; 1999 Oct; 13(13):1658-76. PubMed ID: 10506570
[TBL] [Abstract][Full Text] [Related]
37. The catalytic domain limits the translocation of protein kinase C alpha in response to increases in Ca2+ and diacylglycerol.
Raghunath A; Ling M; Larsson C
Biochem J; 2003 Mar; 370(Pt 3):901-12. PubMed ID: 12460119
[TBL] [Abstract][Full Text] [Related]
38. The C1B domains of novel PKCε and PKCη have a higher membrane binding affinity than those of the also novel PKCδ and PKCθ.
Egea-Jiménez AL; Corbalán-García S; Gómez-Fernández JC
Biochim Biophys Acta; 2014 Jul; 1838(7):1898-909. PubMed ID: 24732301
[TBL] [Abstract][Full Text] [Related]
39. Conformationally constrained analogues of diacylglycerol. 10. Ultrapotent protein kinase C ligands based on a racemic 5-disubstituted tetrahydro-2-furanone template.
Sharma R; Lee J; Wang S; Milne GW; Lewin NE; Blumberg PM; Marquez VE
J Med Chem; 1996 Jan; 39(1):19-28. PubMed ID: 8568806
[TBL] [Abstract][Full Text] [Related]
40. Conformationally constrained analogues of diacylglycerol. 12. Ultrapotent protein kinase C ligands based on a chiral 4,4-disubstituted heptono-1,4-lactone template.
Lee J; Sharma R; Wang S; Milne GW; Lewin NE; Szallasi Z; Blumberg PM; George C; Marquez VE
J Med Chem; 1996 Jan; 39(1):36-45. PubMed ID: 8568825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
